Michael J. Welsh is Director at CANCER GENETICS, INC (CGIX). They have made 1 open-market trade across 1 company since 2016, most recently 2017-09-28.
CIK 0001605868
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $97 since 2016, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| CGIX | 12,540 | $58K |
Shares reported on the most recent Form 4, priced at the 2017-10-02 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CGIX | BUY | 2016-03-16 | 2016-03-17 | $2.42 | $97 | +2.7% | +0.0% | -19.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.